J & J shares dip after massive talcum powder judgment

FAN Editor

Johnson & Johnson is already feeling the sting after a St. Louis jury awarded $4.7 billion in total damages to 22 women and their families who blame asbestos in the consumer-products company’s talcum powder for their ovarian cancer.

After falling nearly 3 percent in pre-market trading, shares of the company were lately down nearly 1 percent. 

The company plans to appeal the ruling, saying it is “deeply disappointed” in the verdict and calling the legal process around the case as “fundamentally unfair.”

“The result of the verdict, which awarded the exact same amounts to all plaintiffs irrespective of their individual facts, and differences in applicable law, reflects that the evidence in the case was simply overwhelmed by the prejudice of this type of proceeding,” the company said in a statement on Thursday.

The company has been sued by more than 9,000 women who claim its talcum powder contributed to their ovarian cancer. Johnson & Johnson has consistently denied that its products can be linked to the cancer.

© 2018 CBS Interactive Inc.. All Rights Reserved.

Free America Network Articles

Leave a Reply

Next Post

Attorney: J&J won't be 'intimidated' into removing talc products after $4.7 billion cancer case damages

Johnson & Johnson lead attorney Bart Williams told CNBC on Friday that talc-based products, such as Baby Powder and other cosmetics, have been proven safe over and over by the “best scientists in America.” J&J shares on Friday were lower after the company late Thursday was ordered to pay a […]

You May Like